William Garner

USPTO Granted Patents = 12 (Patent Applications = 5)

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 140(Granted Patents)

Company Filing History:

Years Active: 2013-2022

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11426381 - Lipoic acid choline ester compositions and methods of use (2022-08-30),

2. 10039743 - Method of treating presbyopia using dithiol compounds and their derivatives (2018-08-07),

3. 9567314 - Dithiol compounds, derivatives, and uses therefor (2017-02-14),

4. 9517225 - Low dose lipoic acid pharmaceutical compositions and methods (2016-12-13),

5. 9326970 - Choline esters (2016-05-03),

6. 9284305 - Methods of treating ocular diseases using derivatives of lipoic acid (2016-03-15),

7. 9161931 - Dithiol compounds and treatment of presbyopia using said compounds (2015-10-20),

8. 9044439 - Low dose lipoic and pharmaceutical compositions and methods (2015-06-02),

9. 8795706 - Methods of treating ocular diseases using derivatives of lipoic acid (2014-08-05),

10. 8697109 - Caged mercaptan and seleno-mercaptan compounds and methods of using them (2014-04-15),

11. 8647612 - Dithiol compounds, derivatives, and treatment of presbyopia (2014-02-11),

12. 8410162 - Choline esters (2013-04-02),

Title: The Innovations of William Garner

Introduction

William Garner is a notable inventor based in Eastport, ME (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work focuses on innovative compositions and methods that address various ocular diseases and other health-related issues.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Lipoic acid choline ester compositions and methods of use." This patent describes pharmaceutical compositions that include a therapeutically effective amount of lipoic acid choline ester or its derivatives, combined with a non-aqueous excipient mixed in an aqueous solution. Additionally, he has developed non-aqueous compositions that can be further mixed with aqueous solutions. Another significant patent is for a "Method of treating presbyopia using dithiol compounds and their derivatives." This invention discloses dithiol compounds that are particularly useful for treating ocular diseases, especially presbyopia and cataracts.

Career Highlights

William Garner has worked with prominent companies in the pharmaceutical industry, including Encore Health LLC and Novartis AG. His experience in these organizations has allowed him to refine his skills and contribute to the development of innovative health solutions.

Collaborations

Throughout his career, Garner has collaborated with various professionals, including Margaret Garner and George Edward Minno. These collaborations have played a crucial role in enhancing his research and development efforts.

Conclusion

William Garner's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his dedication to improving health outcomes. His work continues to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.